Exelixis (EXEL) EBT Margin (2010 - 2026)
Exelixis (EXEL) posted EBT Margin of 41.78% for Q2 2027, up 1.23 percentage points from 40.55% a year earlier but down 2.04 percentage points from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) EBT Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jul 3, 2026, EBT Margin at Exelixis was 42.51%, up 7.73 percentage points year-over-year; for FY2026, it was 40.57%, up 9.14 percentage points from FY2025.
- Annual EBT Margin shows a five-year change of +20.07 percentage points (FY2021 to FY2026).
- In prior years, Exelixis' EBT Margin was 31.43% in FY2025, 14.07% in FY2023 (-0.48 pp) and 14.55% in FY2022 (-5.95 pp).
- Quarterly EBT Margin has run from a low of 11.59% in Q1 2025 to a high of 45.96% in Q2 2025 over five years.
- On a year-over-year basis, EBT Margin has increased in each of the last four quarters, with an average year-over-year change of +8.54 percentage points over the last six quarters.
- According to Business Quant data, EBT Margin for the three prior quarters was 43.82% (Q1 2027), 42.21% (Q4 2026) and 42.23% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 41.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 41.78% |
| Apr 3, 2026 | 43.82% |
| Jan 2, 2026 | 42.21% |
| Oct 3, 2025 | 42.23% |
| Jul 4, 2025 | 40.55% |
| Apr 4, 2025 | 37.03% |
| Jan 3, 2025 | 32.60% |
| Sep 27, 2024 | 28.68% |
| Jun 28, 2024 | 45.96% |
| Mar 29, 2024 | 11.59% |
| Dec 29, 2023 | 21.48% |
| Sep 29, 2023 | 1.23% |
| Jun 30, 2023 | 21.37% |
| Mar 31, 2023 | 11.81% |
| Dec 30, 2022 | -7.41% |
| Sep 30, 2022 | 22.35% |
| Jul 1, 2022 | 21.10% |
| Apr 1, 2022 | 23.94% |
| Oct 1, 2021 | 16.22% |
| Jul 2, 2021 | 32.42% |
API Access
Exelixis EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();